Back to Directory

Andrea McMunn

Email

andrea.mcmunn@nih.gov

Phone

240-571-1945

Institution

NIH, NIAID, DAIDS, PAB

Address

DAIDS Pharmaceutical Affairs Branch
NIH, NIAID, DAIDS, PAB
5601 Fishers Lane, Rm Hoteling
Rockville, MD 20852
USA

Request an Update

Affiliated Studies

IMPAACT 2047: Radiant-Moms Plus

DAIDS Number

Research Area

Study Status

IMPAACT 2017: MOCHA

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

DAIDS Number

Research Area

Study Status

Closed to Follow Up

IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age

DAIDS Number

Research Area

Study Status

IMPAACT 2041: Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women with Hepatitis C with and without HIV

DAIDS Number

Research Area

Study Status

Show All